María E. Suarez‐Almazor

41.8k total citations · 6 hit papers
404 papers, 24.1k citations indexed

About

María E. Suarez‐Almazor is a scholar working on Rheumatology, Oncology and Surgery. According to data from OpenAlex, María E. Suarez‐Almazor has authored 404 papers receiving a total of 24.1k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Rheumatology, 98 papers in Oncology and 60 papers in Surgery. Recurrent topics in María E. Suarez‐Almazor's work include Rheumatoid Arthritis Research and Therapies (99 papers), Cancer Immunotherapy and Biomarkers (51 papers) and Chronic Lymphocytic Leukemia Research (49 papers). María E. Suarez‐Almazor is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (99 papers), Cancer Immunotherapy and Biomarkers (51 papers) and Chronic Lymphocytic Leukemia Research (49 papers). María E. Suarez‐Almazor collaborates with scholars based in United States, Canada and Vietnam. María E. Suarez‐Almazor's co-authors include María A. López-Olivo, Éduardo Bruera, Noha Abdel‐Wahab, José A. Maldonado‐Cocco, David N. Glass, Javier Orozco-Alcalá, John Baum, T. R. E. Southwood, Ross E. Petty and Prudence Manners and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

María E. Suarez‐Almazor

392 papers receiving 23.3k citations

Hit Papers

International League of Associations for Rheumatology cla... 1999 2026 2008 2017 2004 2020 2001 2000 1999 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.
    2004 3.1k citations María E. Suarez‐Almazor et al. PubMed profile →
  2. Immune-related adverse events of checkpoint inhibitors
    2020 931 citations Julie R. Brahmer, María E. Suarez‐Almazor et al. profile →
  3. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997
    2001 875 citations María E. Suarez‐Almazor et al. PubMed profile →
  4. Occurrence, Causes, and Outcome of Delirium in Patients With Advanced Cancer
    2000 561 citations Peter G. Lawlor, Bruno Gagnon et al. profile →
  5. Health services research
    1999 502 citations María E. Suarez‐Almazor et al. profile →
  6. Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease
    2018 340 citations Noha Abdel‐Wahab, María A. López-Olivo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María E. Suarez‐Almazor United States 79 6.2k 5.2k 4.9k 4.4k 2.9k 404 24.1k
Maarten Boers Netherlands 79 14.5k 2.3× 4.4k 0.8× 5.1k 1.0× 1.6k 0.4× 2.5k 0.9× 468 32.7k
Kenneth G. Saag United States 86 7.4k 1.2× 6.0k 1.2× 2.5k 0.5× 5.1k 1.1× 1.4k 0.5× 476 26.7k
Daniel H. Solomon United States 96 13.5k 2.2× 7.5k 1.4× 2.8k 0.6× 3.6k 0.8× 2.1k 0.7× 585 36.0k
Matthew H. Liang United States 62 19.8k 3.2× 6.9k 1.3× 4.9k 1.0× 2.3k 0.5× 1.9k 0.7× 193 37.3k
Jennifer J. Anderson United States 62 10.0k 1.6× 4.2k 0.8× 3.0k 0.6× 1.3k 0.3× 1.3k 0.5× 132 21.8k
Sherine E. Gabriel United States 76 16.4k 2.6× 5.3k 1.0× 3.2k 0.7× 1.2k 0.3× 1.1k 0.4× 202 29.3k
George D. Kitas United Kingdom 65 8.7k 1.4× 1.8k 0.4× 2.7k 0.6× 1.8k 0.4× 817 0.3× 460 19.6k
Deborah Symmons United Kingdom 87 16.0k 2.6× 2.7k 0.5× 5.1k 1.0× 1.3k 0.3× 1.4k 0.5× 396 27.2k
Jasvinder A. Singh United States 77 6.3k 1.0× 10.2k 2.0× 1.6k 0.3× 889 0.2× 1.3k 0.5× 572 22.7k
Tore K Kvien Norway 84 18.4k 3.0× 3.8k 0.7× 5.4k 1.1× 1.1k 0.3× 1.0k 0.4× 537 28.6k

Countries citing papers authored by María E. Suarez‐Almazor

Since Specialization
Citations

This map shows the geographic impact of María E. Suarez‐Almazor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María E. Suarez‐Almazor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María E. Suarez‐Almazor more than expected).

Fields of papers citing papers by María E. Suarez‐Almazor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María E. Suarez‐Almazor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María E. Suarez‐Almazor. The network helps show where María E. Suarez‐Almazor may publish in the future.

Co-authorship network of co-authors of María E. Suarez‐Almazor

This figure shows the co-authorship network connecting the top 25 collaborators of María E. Suarez‐Almazor. A scholar is included among the top collaborators of María E. Suarez‐Almazor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María E. Suarez‐Almazor. María E. Suarez‐Almazor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
López-Olivo, María A., et al.. (2025). Physician Views and Attitudes Regarding Tobacco‐Cessation Strategies for Patients with Rheumatoid Arthritis. Arthritis Care & Research. 77(6). 767–776. 1 indexed citations
2.
Mammen, Andrew L., et al.. (2024). Immune Checkpoint Inhibitor-induced Myositis. Rheumatic Disease Clinics of North America. 50(2). 281–290. 5 indexed citations
3.
Lei, Xiudong, Chi‐Fang Wu, Hui Zhao, et al.. (2024). Utilization of Biologic Disease‐Modifying Antirheumatic Therapy in Patients With Rheumatoid Arthritis and Recently Diagnosed Breast Cancer. Arthritis Care & Research. 76(6). 850–859. 2 indexed citations
4.
Ye, Carrie, et al.. (2024). Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitors. SHILAP Revista de lepidopterología. 3(1). e000398–e000398. 4 indexed citations
5.
López-Olivo, María A., Gabrielle F. Duhon, Mehmet Altan, et al.. (2023). Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study. Cancers. 15(10). 2690–2690. 4 indexed citations
6.
López-Olivo, María A., et al.. (2023). COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review. SHILAP Revista de lepidopterología. 6(2). 103–110. 2 indexed citations
7.
López-Olivo, María A., et al.. (2023). COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Journal for ImmunoTherapy of Cancer. 11(2). e006246–e006246. 19 indexed citations
8.
Naidoo, Jarushka, Catherine J. Murphy, Michael B. Atkins, et al.. (2023). Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology. Journal for ImmunoTherapy of Cancer. 11(3). e006398–e006398. 73 indexed citations
9.
Bruera, Sebastian, Xiudong Lei, Hui Zhao, et al.. (2023). Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus. Lupus Science & Medicine. 10(1). e000750–e000750. 12 indexed citations
10.
DiPeri, Timothy P., Daniel D. Karp, Siqing Fu, et al.. (2022). Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma. SHILAP Revista de lepidopterología. 5(1). 26–30.
11.
López-Olivo, María A., et al.. (2021). Quality appraisal of educational websites about osteoporosis and bone health. Archives of Osteoporosis. 16(1). 28–28. 1 indexed citations
12.
Lu, Huifang, Xiudong Lei, Hui Zhao, et al.. (2020). Bone Mineral Density at the Time of Initiating Aromatase Inhibitor Therapy Is Associated With Decreased Fractures in Women With Breast Cancer. Journal of Bone and Mineral Research. 36(5). 861–871. 9 indexed citations
13.
Torres, Harrys A., Anna S. Lok, María E. Suarez‐Almazor, et al.. (2020). Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Supportive Care in Cancer. 29(1). 97–105. 1 indexed citations
14.
Riehm, Kira E., Linda Kwakkenbos, Marie‐Eve Carrier, et al.. (2015). Validation of the Self‐Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient‐Centered Intervention Network Cohort Study. Arthritis Care & Research. 68(8). 1195–1200. 29 indexed citations
15.
Suarez‐Almazor, María E., et al.. (2011). Neoplastic and Paraneoplastic Synovitis. Rheumatic Disease Clinics of North America. 37(4). 551–572. 12 indexed citations
16.
Kirwan, John, Stanton Newman, Peter Tugwell, et al.. (2009). Progress on Incorporating the Patient Perspective in Outcome Assessment in Rheumatology and the Emergence of Life Impact Measures at OMERACT 9. The Journal of Rheumatology. 36(9). 2071–2076. 33 indexed citations
17.
Massardo, Loreto, María E. Suarez‐Almazor, Mario H. Cardiel, et al.. (2009). Management of Patients With Rheumatoid Arthritis in Latin America. JCR Journal of Clinical Rheumatology. 15(4). 203–210. 35 indexed citations
18.
Ashton, Carol M., Paul Haidet, Debora A. Paterniti, et al.. (2003). Racial and ethnic disparities in the use of health services. Journal of General Internal Medicine. 18(2). 146–152. 404 indexed citations
19.
Greisinger, Anthony, Marsha Richardson, Kimberly J. OʼMalley, et al.. (2003). Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.. PubMed. 32(3). 103–122. 110 indexed citations
20.
Lawlor, Peter G., Bruno Gagnon, Isabelle Mancini, et al.. (2001). Clinical and Ethical Questions Concerning Delirium Study on Patients With Advanced Cancer—Reply. JAMA Internal Medicine. 161(2). 297–297. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maarten Boers Breakdown of academic impact, for papers by Kenneth G. Saag Breakdown of academic impact, for papers by Daniel H. Solomon Breakdown of academic impact, for papers by Matthew H. Liang Breakdown of academic impact, for papers by Jennifer J. Anderson Breakdown of academic impact, for papers by Sherine E. Gabriel Breakdown of academic impact, for papers by George D. Kitas Breakdown of academic impact, for papers by Deborah Symmons Breakdown of academic impact, for papers by Jasvinder A. Singh Breakdown of academic impact, for papers by Tore K Kvien
Rankless by CCL
2026